Who owns the QUILLIVANT XR trademark?

The QUILLIVANT XR trademark is owned by NextWave Pharmaceuticals, Inc..

What class is the QUILLIVANT XR trademark registered in?

The QUILLIVANT XR trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for QUILLIVANT XR?

The USPTO serial number for QUILLIVANT XR is 85704149.

What is the registration number for QUILLIVANT XR?

QUILLIVANT XR is registered under USPTO registration number 4511557.

QUI

USPTO Trademark Record

REGISTERED

QUILLIVANT XR

SN 85704149·Reg 4511557·Filed Aug 15, 2012

Owner NextWave Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

QUILLIVANT XR (Serial No. 85704149), Registration No. 4511557, is a registered US trademark filed on Aug 15, 2012 by NextWave Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Section 8/9 declaration window: April 10, 2034

Mark Intelligence

QUILLIVANT XR (Reg. #4511557) is a registered US trademark that has been protecting its owner, NextWave Pharmaceuticals, Inc., since 2012. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 15, 2012

SERIAL

85704149

REG#

4511557

REGISTERED

Apr 08, 2014

Owner

Applicant

NextWave Pharmaceuticals, Inc.

Entity

Corporation

State

Address

TRIS PHARMA, 2031 US Highway 130, Monmouth Junction, NJ, 08852

Country

Attorney

NameCathy A. Kodroff

Law firm

Cathy A. Kodroff HOWSON & HOWSON

Docket

TRIS-QUILLXR

Address

325 Sentry Parkway East, Five Sentry East, Suite 160, Blue Bell, PA 19422, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateAug 15, 2012

Serial Number85704149

Registration No.4511557

Registration DateApr 08, 2014

Status DateJul 08, 2024

Published for OppositionJun 18, 2013

Next RenewalApril 10, 2034

Mark TypeStandard characters

Attorney DocketTRIS-QUILLXR

Status DescriptionLive and registered, renewed

Filing Signals

FILED

2012

YEARS AGO

14y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Jan 14, 2013

First use in commerce: Jan 14, 2013

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

46 events

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Jul 08, 2024

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Jul 08, 2024

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Jul 08, 2024

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jul 05, 2024

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 & 9 RECEIVED

Apr 08, 2024

TEAS SECTION 8 & 9 RECEIVED

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Apr 08, 2023

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Aug 26, 2019

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Aug 26, 2019

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Aug 26, 2019

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

Jul 16, 2019

TEAS SECTION 8 & 15 RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 16, 2019

TEAS CHANGE OF CORRESPONDENCE RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Apr 08, 2019

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Feb 05, 2019

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Feb 05, 2019

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Oct 03, 2018

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

REGISTERED-PRINCIPAL REGISTER

Apr 08, 2014

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 01, 2014

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 28, 2014

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

LAW OFFICE REGISTRATION REVIEW COMPLETED

Feb 28, 2014

LAW OFFICE REGISTRATION REVIEW COMPLETED

SOU EXTENSION 1 GRANTED

Feb 27, 2014

SOU EXTENSION 1 GRANTED

STATEMENT OF USE PROCESSING COMPLETE

Feb 27, 2014

STATEMENT OF USE PROCESSING COMPLETE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 27, 2014

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 24, 2014

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 24, 2014

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 1 FILED

Jan 27, 2014

SOU EXTENSION 1 FILED

SOU TEAS EXTENSION RECEIVED

Jan 27, 2014

SOU TEAS EXTENSION RECEIVED

TEAS STATEMENT OF USE RECEIVED

Jan 27, 2014

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jan 27, 2014

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 13, 2013

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 18, 2013

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 18, 2013

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 29, 2013

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

May 16, 2013

LAW OFFICE PUBLICATION REVIEW COMPLETED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 14, 2013

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 14, 2013

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 14, 2013

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

May 07, 2013

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 02, 2013

TEAS RESPONSE TO OFFICE ACTION RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Dec 13, 2012

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Dec 13, 2012

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

ASSIGNED TO EXAMINER

Dec 11, 2012

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Dec 11, 2012

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 11, 2012

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 11, 2012

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 22, 2012

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 18, 2012

NEW APPLICATION ENTERED

QUILLIVANT XR

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by NextWave Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Cathy A. Kodroff

Resources

Company